Latest stories on LTGO
Goldman Sachs reiterates Latigo Biotherapeutics stock buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Latigo Biotherapeutics, Inc. reports Q2 results
Seeking Alpha50 · neutralearnings
Latigo Biotherapeutics, Inc. (LTGO) files 8-K
SEC 8-K50 · neutralgeneral
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Business Insider24 · bearishgeneral
Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire24 · bearishgeneral
Jefferies initiates Latigo Biotherapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Latigo Biotherapeutics initiated with a Buy at Jefferies
The Fly61 · neutralanalyst
Latigo Biotherapeutics initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Latigo Biotherapeutics initiated with a Buy at Guggenheim
The Fly61 · neutralanalyst
Latigo Biotherapeutics initiated with a Buy at Goldman Sachs
The Fly61 · neutralanalyst
Goldman Sachs initiates Latigo Biotherapeutics stock with buy rating on pain drug potential
Investing.com Analyst Ratings61 · neutralanalyst
Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public
Yahoo Finance58 · neutralgeneral
Latigo Biotherapeutics, Inc. (LTGO) files 8-K
SEC 8-K50 · neutralgeneral
Latigo Biotherapeutics shares jump 17% after upsized IPO
Investing.com Markets63 · neutralgeneral
Pain drug developer Latigo climbs after upsized IPO
Seeking Alpha58 · neutralgeneral
Non-Opioid Painkiller Maker Latigo Shares Edge Up After IPO
Bloomberg58 · neutralgeneral
Latigo Biotherapeutics opens at $21, IPO priced at $18 per share
The Fly59 · neutralearnings
Latigo Biotherapeutics Indicated To Open At 20 Ipo Priced At 18
The Fly58 · neutralgeneral
Latigo IPO raises nearly $350M for pain drug development
Yahoo Top63 · neutralgeneral
Latigo Biotherapeutics 19.2M share IPO priced at $18.00
The Fly59 · neutralgeneral
Non-Opioid Painkiller Maker Latigo Raises $345.6 Million in IPO
Bloomberg58 · neutralgeneral
Latigo Biotherapeutics prices $345.6M IPO at $18 per share
Investing.com Markets28 · bearishgeneral
Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering
StockTitan24 · bearishgeneral
Latigo, BlossomHill launch US IPOs as biotech listings rebound
Reuters58 · neutralgeneral
Latigo Biotherapeutics seeks to raise up to $288m in IPO
Investing.com Markets28 · bearishgeneral